We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$14.4B
AUM Growth
+$865M
Cap. Flow
+$521M
Cap. Flow %
3.62%
Top 10 Hldgs %
10.5%
Holding
1,681
New
566
Increased
330
Reduced
298
Closed
480

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.22%
2 Healthcare 12.42%
3 Financials 9.84%
4 Technology 8.72%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
251
DELISTED
Xilinx Inc
XLNX
$16M 0.11%
340,549
-504,887
-60% -$23.9M
LLY icon
252
Eli Lilly
LLY
$1.06T
$15.9M 0.11%
188,930
-45,780
-20% -$3.8M
MAT icon
253
Mattel
MAT
$4.23B
$15.9M 0.11%
+585,711
New +$14.4M
FLEX icon
254
Flex
FLEX
$44.8B
$15.8M 0.11%
+1,871,358
New +$15.8M
GOOGL icon
255
PUT
Alphabet (Google) Class A
GOOGL
$4.33T
$15.6M 0.11%
400,000
+170,000
+74% +$6.29M
CLNY
256
DELISTED
Colony Capital, Inc.
CLNY
$15.5M 0.11%
793,359
+724,637
+1,054% +$14.8M
BOH icon
257
Bank of Hawaii
BOH
$3.13B
$15.4M 0.11%
+245,252
New +$16.1M
ADPT
258
DELISTED
Adeptus Health Inc
ADPT
$15.3M 0.11%
280,587
+99,380
+55% +$6.34M
PRKS icon
259
United Parks & Resorts
PRKS
$2.12B
$15.2M 0.11%
769,946
+751,046
+3,974% +$13.9M
ADBE icon
260
Adobe
ADBE
$105B
$15M 0.1%
159,875
+48,985
+44% +$4.4M
BSX icon
261
Boston Scientific
BSX
$71.5B
$15M 0.1%
811,023
+318,423
+65% +$5.71M
XLI icon
262
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$14.9M 0.1%
+281,250
New +$15.1M
TRVN
263
DELISTED
Trevena, Inc.
TRVN
$14.8M 0.1%
2,255
-18
-0.8% -$121K
HOT
264
CALL
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$14.8M 0.1%
+213,400
New +$15.2M
CSCO icon
265
Cisco
CSCO
$479B
$14.7M 0.1%
541,846
+368,646
+213% +$10.2M
NKE icon
266
Nike
NKE
$61.9B
$14.7M 0.1%
234,789
-154,351
-40% -$9.96M
SGMO
267
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14.7M 0.1%
1,604,890
+1,527,638
+1,977% +$11.8M
CLX icon
268
Clorox
CLX
$12.7B
$14.6M 0.1%
+115,442
New +$14.3M
MSTR icon
269
CALL
Strategy Inc
MSTR
$38.4B
$14.5M 0.1%
+809,000
New +$14.7M
TMO icon
270
Thermo Fisher Scientific
TMO
$220B
$14.4M 0.1%
101,773
-118,170
-54% -$15.8M
PNW icon
271
Pinnacle West Capital
PNW
$12.2B
$14.3M 0.1%
222,049
-167,727
-43% -$10.7M
TOL icon
272
Toll Brothers
TOL
$14.5B
$14.3M 0.1%
429,818
-1,298,953
-75% -$46.3M
MELI icon
273
PUT
Mercado Libre
MELI
$92.3B
$14.3M 0.1%
+125,000
New +$13.7M
ANF icon
274
Abercrombie & Fitch
ANF
$5B
$14.2M 0.1%
+527,369
New +$12.2M
EQT icon
275
EQT Corp
EQT
$32.3B
$14.2M 0.1%
+500,922
New +$16.8M

Similar funds

Balyasny Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Balyasny Asset Management held 1,681 positions worth $14.4B, up 6.4% from $13.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Balyasny Asset Management deployed $521M of net new capital in Q4 2015, opening 566 new positions and adding to 330 existing holdings. Its largest new stake was Alphabet (Google) Class A: 4,979,180 shares worth $194M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was United Parcel Service, an estimated $174M trimmed.

  • Balyasny Asset Management's largest Q4 2015 buy was Alphabet (Google) Class A: 4,979,180 shares worth $194M.
  • Balyasny Asset Management added most to Teva Pharmaceuticals in Q4 2015, an estimated $131M increase.
  • Balyasny Asset Management's biggest Q4 2015 reduction was United Parcel Service, cutting an estimated $174M.
  • Balyasny Asset Management fully exited Abbott in Q4 2015, selling an estimated $94.7M.
  • Balyasny Asset Management's ten largest holdings make up 10% of its $14.4B portfolio in Q4 2015.
  • Balyasny Asset Management opened 566 new positions and closed 480 in Q4 2015.
  • Balyasny Asset Management's portfolio value rose 6.4% quarter-over-quarter to $14.4B.

Based on Balyasny Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.